昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

68.500

+5.650

+8.99%

最高--	最低--	成交量77.87万
今开--	昨收62.850	日振幅8.91%
总市值261.42亿	流通市值41.59亿	总股本3.82亿
成交额5,240万	换手率1.28%	流通股本6,071万
市净率3.06	ROE--	每股收益1.77
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

Data provider: Ningxia XSRK Technology Limited

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"market":"HK","stockBase":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":68.5,"timestamp":1656058087023,"preClose":62.85,"halted":0,"volume":778690,"delay":0,"change":5.65,"changeRate":0.089897,"floatShares":60711840,"shares":381633792,"eps":1.7735424,"lyrEps":1.773542,"pbRate":3.06,"psRate":14.03,"amount":52401909,"amplitude":0.089101,"volumeRatio":1.007722564502354,"dividePrice":0.422831,"prevYearClose":65.65,"fiveDayClose":71.7,"twentyDayClose":58.05},"adData":{"groupTypeList":[],"userSplitList":[]},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2245828904","title":"最高超80亿！多家公司密集披露减持计划，频繁套现为哪般？","url":"https://stock-news.laohu8.com/highlight/detail?id=2245828904","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2245828904?lang=zh_CN&edition=full","pubTime":"2022-06-21 16:18","pubTimestamp":1655799480,"startTime":"0","endTime":"0","summary":"数据显示，本月以来已有234家上市公司股东宣布减持计划。有业内人士表示，虽然大宗交易减持并未强制要求预披露，但上市公司因谨慎起见，一般会披露减持计划。浙江世宝此前并未预披露，其控股股东选择此时高位套现显得颇为敏感。多家公司密集披露减持事实上，近期资本市场上各种减持公告满天飞。仅6月20日晚间，就有逾30家上市公司披露减持计划、减持结果以及进展的相关公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/s/2022-06-21/doc-imizirau9773529.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/s/2022-06-21/doc-imizirau9773529.shtml","is_publish_highlight":false},{"id":"2245774694","title":"一则公告干崩“猴茅” 昭衍新药(603127.SH)昨日放量跌停 CRO板块何时会反弹?","url":"https://stock-news.laohu8.com/highlight/detail?id=2245774694","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2245774694?lang=zh_CN&edition=full","pubTime":"2022-06-21 11:08","pubTimestamp":1655780924,"startTime":"0","endTime":"0","summary":"一则公告把“猴茅”干崩了。6月20日，智通财经APP获悉，市值四百多亿的CRO概念股昭衍新药放量大跌。截至当日收盘，股价跌停，一日之间蒸发近50多亿元。根据中国食品药品检定研究院公告，2019年、2021年、2022年1月、2022年2月发布的实验用食蟹猴招标单价分别为3万元、7.05万元、12.2万元和13.25万元。4月28日，昭衍新药披露称拟以9.75亿元收购广西玮美生物科技有限公司100%股权，以8.3亿元收购云南英茂生物科技有限公司100%股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/741833.html","is_publish_highlight":false},{"id":"2245211478","title":"智通港股早知道 | 发改委部署查处煤炭价格超出合理区间行为 第七批国采上海开标","url":"https://stock-news.laohu8.com/highlight/detail?id=2245211478","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2245211478?lang=zh_CN&edition=full","pubTime":"2022-06-21 07:45","pubTimestamp":1655768722,"startTime":"0","endTime":"0","summary":"发改委部署各地开展拉网式调查依法查处煤炭价格超出合理区间的行为近日，在国家发展改革委统一部署下，各地发展改革部门会同市场监管等部门组成调查组，全面开展落实煤炭价格调控监管政策拉网式调查。从反馈的部分调查结果看，已查实一些企业煤炭销售价格超出合理区间。考虑到超出金额较小，当地发展改革部门已对该企业进行了约谈，要求其立即退还多收煤款，并将煤炭销售价格调整至合理区间内。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/741742.html","is_publish_highlight":false},{"id":"2245047819","title":"最新龙虎榜：机构卖出昭衍新药超3亿，知名游资买入科大讯飞","url":"https://stock-news.laohu8.com/highlight/detail?id=2245047819","media":"阿尔法工场研究院","top":-1,"share":"https://www.laohu8.com/m/news/2245047819?lang=zh_CN&edition=full","pubTime":"2022-06-21 07:10","pubTimestamp":1655766600,"startTime":"0","endTime":"0","summary":"【6月20日（周一）龙虎榜，点击可看大图】","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5MzAzNzE0MQ==&mid=2651536168&idx=4&sn=fa1dd9514dd470c79d8354037f73704f&chksm=bd62b5128a153c04fe728183a81fe3a567a315aca4b28d673e94bed723d5b25d867999c002c5#rd","is_publish_highlight":false},{"id":"2245427055","title":"智通A股龙虎榜统计|6月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=2245427055","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2245427055?lang=zh_CN&edition=full","pubTime":"2022-06-21 07:00","pubTimestamp":1655766004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉， 6月20日共有86家公司现身A股龙虎榜。其中，索通发展、宝胜股份、华能国际龙虎榜前5大席位合计净买入金额排名前三，分别是3.51亿元、2.65亿元、1.93亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/741730.html","is_publish_highlight":false},{"id":"2244446036","title":"实验猴要开放进口？ 一则公告引发猴茅跌停 昭衍新药回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2244446036","media":"云财经","top":-1,"share":"https://www.laohu8.com/m/news/2244446036?lang=zh_CN&edition=full","pubTime":"2022-06-20 20:40","pubTimestamp":1655728842,"startTime":"0","endTime":"0","summary":"云财经讯，昭衍新药今日开盘后股价迅速跌停，有投资者认为6月17日发布的关于停止执行《关于禁止野生动物交易的公告》意味着实验猴要开放进口将对昭衍新药相关业务构成重大利空，昭衍新药内部人士回应称：“废止是说老百姓日常用的经济型动物现在可以正常交易了，但是跟（实验）猴是完全不挂钩的，什么时候（实验）猴可以进口还要看未来的动向。放开猴子进口也是种群的进口，不是普通实验用猴，短期内对我们的供给没有影响，本来我们自己的猴子还要从市场采购”。 (中证报)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062020442981fcda5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062020442981fcda5c&s=b","is_publish_highlight":false},{"id":"2245225273","title":"6月20日龙虎榜追踪，机构青睐这些个股","url":"https://stock-news.laohu8.com/highlight/detail?id=2245225273","media":"证券时报e公司","top":-1,"share":"https://www.laohu8.com/m/news/2245225273?lang=zh_CN&edition=full","pubTime":"2022-06-20 18:19","pubTimestamp":1655720347,"startTime":"0","endTime":"0","summary":"6月20日龙虎榜中机构及营业部席位资金净买入3.01亿元，其中净买入的个股有23只；净卖出的个股有15只。净买入金额居前的个股分别是华能国际、科大讯飞、宝胜股份等，净买入金额占当日成交额比例达13.43%、6.30%、14.04%。机构席位净卖出2.53亿元，净买入金额居前的个股分别是华能国际、宝胜股份、格力地产等，净卖出金额居前的个股分别是山西焦煤、昭衍新药、上海能源等。* 此稿由证券时报e公司写稿机器人“快手小e”完成","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5597884738_14da8f14202001i88e.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5597884738_14da8f14202001i88e.html","is_publish_highlight":false},{"id":"2244184064","title":"昭衍新药(06127)获董事姚大林累计减持1.51万股 减持计划尚未实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2244184064","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2244184064?lang=zh_CN&edition=full","pubTime":"2022-06-20 16:55","pubTimestamp":1655715357,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)公布，该公司董事姚大林披露减持计划前持有公司股份6.89万股，占当时的持股比例为0.018%。上述股份来源于股权激励股份及公司资本公积金转增股份等其他方式。姚大林拟自减持计划公告之日起15个交易日后(即5月25日起)的6个月内，通过上海证券交易所集中竞价的交易方式减持不超过1.72万股，不超过公司当时总股本的0.0045%。截止本公告披露日，姚大林减持1.51万股。减持计划尚未实施完毕。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/741308.html","is_publish_highlight":false},{"id":"2244497387","title":"疯抢实验猴","url":"https://stock-news.laohu8.com/highlight/detail?id=2244497387","media":"虎嗅","top":-1,"share":"https://www.laohu8.com/m/news/2244497387?lang=zh_CN&edition=full","pubTime":"2022-06-20 15:55","pubTimestamp":1655711721,"startTime":"0","endTime":"0","summary":"实验猴价格开始朝“离谱”方向涨","market":"sh","thumbnail":"https://img.huxiucdn.com/article/cover/202206/20/141011410016.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg","type":0,"news_type":0,"thumbnails":["https://img.huxiucdn.com/article/cover/202206/20/141011410016.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.huxiu.com/article/586625.html","is_publish_highlight":false},{"id":"2244970334","title":"昭衍新药06月20日主力大幅流出2.29亿元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2244970334","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2244970334?lang=zh_CN&edition=full","pubTime":"2022-06-20 15:13","pubTimestamp":1655709216,"startTime":"0","endTime":"0","summary":"06月20日, 昭衍新药股价跌10.00%，报收112.81元，成交金额10.57亿元，换手率2.89%，振幅9.80%，量比2.88。昭衍新药今日主力资金净流出2.29亿元，上一交易日主力净流入3430万元。该股近5个交易日下跌0.72%，主力资金累计净流出2.17亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出3.54亿元，其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062015161584581210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062015161584581210&s=b","is_publish_highlight":false},{"id":"2244464323","title":"港股异动 | 昭衍新药(06127)跌超10% 公司A股跌停 国金指三部委通知对商品猴供需无直接影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2244464323","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2244464323?lang=zh_CN&edition=full","pubTime":"2022-06-20 10:28","pubTimestamp":1655692127,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，昭衍新药早盘显著受挫，一度跌13%，同时，公司A股放量跌停。国金点评称，其对商品猴供需没有直接影响，短期继续看22H2商品猴价格稳中有升。截至发稿，昭衍新药跌10.39%，报64.25港元，成交额0.28亿港元。6月17日，国家林业和草原局等三部委联合决定停止执行《关于禁止野生动物交易的公告》。昭衍新药是国内安评行业龙头，业务聚焦于临床前研究服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/741106.html","is_publish_highlight":false},{"id":"2245259473","title":"两市主力资金开盘净流出69.60亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2245259473","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2245259473?lang=zh_CN&edition=full","pubTime":"2022-06-20 10:10","pubTimestamp":1655691018,"startTime":"0","endTime":"0","summary":"证券时报数据宝统计显示，截至上午10时，两市主力资金开盘净流出69.60亿元，其中，深市主板净流出27.91亿元，创业板净流入4.05亿元，沪市主板净流出47.73亿元，科创板资金净流入2.00亿元。以所属概念统计，截至发稿，涨幅居前的概念有两轮车、租售同权、噪声防治等，其中，两轮车上涨3.10%，开盘主力资金净流入3070.83万元，租售同权上涨2.14%，开盘主力资金净流入1.51亿元，噪声防治上涨2.13%，开盘主力资金净流入2663.50万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/jjxw/2022-06-20/doc-imizmscu7741190.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/jjxw/2022-06-20/doc-imizmscu7741190.shtml","is_publish_highlight":false},{"id":"2243718321","title":"昭衍新药06月16日获主力加仓1589万元 环比增加808.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2243718321","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2243718321?lang=zh_CN&edition=full","pubTime":"2022-06-16 15:14","pubTimestamp":1655363692,"startTime":"0","endTime":"0","summary":"06月16日, 昭衍新药股价涨2.74%，报收118.94元，成交金额3.15亿元，换手率0.82%，振幅5.97%，量比0.85。昭衍新药今日主力资金净流入1589万元，上一交易日主力净流入175万元，今日环比增加808.00%。该股近5个交易日上涨0.98%，主力资金累计净流出3192万元；近20日主力资金累计净流出1.74亿元，其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220616152150828aa1e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220616152150828aa1e8&s=b","is_publish_highlight":false},{"id":"2243732529","title":"港股异动 | CRO概念股走高 维亚生物(01873)盘中涨超12% 凯莱英(06821)涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2243732529","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2243732529?lang=zh_CN&edition=full","pubTime":"2022-06-16 11:40","pubTimestamp":1655350822,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股早盘走高，截至发稿，维亚生物(01873)涨9.75%，报2.59港元；凯莱英(06821)涨4.12%，报164.1港元；昭衍新药(06127)涨2.56%，报70.1港元；泰格医药(03347)涨1.9%，报80.6港元。光大证券表示，全球生物药市场规模不断扩大，研发热情高涨，新药研发成本快速攀升及药企对CXO公司的依赖增强，催生了生物药CXO市场的需求快速增长。根据Frost&Sullivan统计，全球生物药CDMO市场有望于2025年达到254亿美元，中国生物药CDMO市场有望于2023年达到44亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/739618.html","is_publish_highlight":false},{"id":"2244395117","title":"昭衍新药06月15日获沪股通增持4.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2244395117","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2244395117?lang=zh_CN&edition=full","pubTime":"2022-06-16 09:02","pubTimestamp":1655341320,"startTime":"0","endTime":"0","summary":"06月15日，昭衍新药获沪股通增持4.84万股，最新持股量为689.14万股，占公司A股总股本的2.15%。近五日持股量数据持股量及股价变动图股民福利来了！十大金股送给你，带你掘金“黄金坑”！点击查看>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/cn/2022-06-16/doc-imizirau8776564.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/cn/2022-06-16/doc-imizirau8776564.shtml","is_publish_highlight":false},{"id":"2243188911","title":"昭衍新药(06127.HK)：玮美生物完成股权转让相关工商变更登记备案手续","url":"https://stock-news.laohu8.com/highlight/detail?id=2243188911","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2243188911?lang=zh_CN&edition=full","pubTime":"2022-06-15 17:37","pubTimestamp":1655285852,"startTime":"0","endTime":"0","summary":"格隆汇6月15日丨昭衍新药(06127.HK)发布公告，关于收购广西玮美生物科技有限公司100%股权，近日，玮美生物已完成本次股权转让相关的工商变更登记备案手续，并已取得新的《营业执照》。本次工商变更完成后，玮美生物成为公司的全资子公司，将纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022061517373284570436&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022061517373284570436&s=b","is_publish_highlight":false},{"id":"2243998248","title":"昭衍新药(06127)：玮美生物已成为公司全资子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2243998248","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2243998248?lang=zh_CN&edition=full","pubTime":"2022-06-15 17:37","pubTimestamp":1655285846,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，关于收购广西玮美生物科技有限公司100%股权的进展，近日，广西玮美生物科技有限公司(玮美生物)已完成本次股权转让相关的工商变更登记备案手续，并已取得新的《营业执照》。本次工商变更完成后，玮美生物成为公司的全资子公司，将纳入公司合并报表范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/739187.html","is_publish_highlight":false},{"id":"2243203196","title":"昭衍新药06月14日收涨1.88% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2243203196","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2243203196?lang=zh_CN&edition=full","pubTime":"2022-06-14 15:13","pubTimestamp":1655190801,"startTime":"0","endTime":"0","summary":"06月14日, 昭衍新药股价涨1.88%，报收115.77元，成交金额3.01亿元，换手率0.82%，振幅4.87%，量比0.63。昭衍新药今日主力资金净流出4055万元，上一交易日主力净流出4844万元，今日环比减少16.29%。该股近5个交易日上涨2.45%，主力资金累计净流出2369万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出2.06亿元，其中净流出天数为16日。该股主力净额占比0.11%，A股市场排名3101/4882，高于行业平均值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220614151503828a7488&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220614151503828a7488&s=b","is_publish_highlight":false},{"id":"2243620316","title":"CRO“囤猴热”：昭衍新药、康龙化成、药明康德相继出手，美迪西称在考虑","url":"https://stock-news.laohu8.com/highlight/detail?id=2243620316","media":"和讯股票","top":-1,"share":"https://www.laohu8.com/m/news/2243620316?lang=zh_CN&edition=full","pubTime":"2022-06-14 15:04","pubTimestamp":1655190251,"startTime":"0","endTime":"0","summary":"自建+收购 昭衍新药否认“囤猴”、为满足自己使用今年4月29日，昭衍新药连发2份公告，收购广西玮美生物和云南英茂生物两家实验动物模型公司各100%股权。6月6月，昭衍新药公告表示，英茂生物已成为公司全资子公司。康龙化成：研发自用、后续收购计划不确定2021年，康龙化成两度出手收购相关公司，满足自己的实验动物供应需要。头部CRO企业中，药明康德出手地更早。截至目前，美迪西公告中并没有相关动作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022061415044981f9a873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022061415044981f9a873&s=b","is_publish_highlight":false},{"id":"2243351956","title":"昭衍新药(06127)监事拟合计减持不超3.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2243351956","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2243351956?lang=zh_CN&edition=full","pubTime":"2022-06-13 16:54","pubTimestamp":1655110478,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布北京昭衍新药研究中心股份有限公司监事集中竞价减持股份计划公告。监事孙辉业、尹丽莉、李叶拟自本减持计划公告之日起15个交易日后(即7月5日起)的6个月内，通过上海证券交易所集中竞价的交易方式分别减持不超过1万股、1.1万股、1.3万股，合计减持不超过3.4万股，不超过公司当前总股本的0.01%。减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发新股或配股等股本除权、除息事项的，减持数量将进行相应调整。减持价格依据市场价格确定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/737746.html","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0446},{"period":"1month","weight":0.1445},{"period":"3month","weight":-0.0207},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.452},{"period":"ytd","weight":0.0434}],"websiteUrl":null,"compareEarnings":[{"period":"1week","weight":0.0306},{"period":"1month","weight":0.0767},{"period":"3month","weight":0.0147},{"period":"6month","weight":-0.0648},{"period":"1year","weight":-0.248},{"period":"ytd","weight":-0.0717}],"name":"昭衍新药","description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。非临床研究服务包括药物安全性评价、药代动力学研究以及药理和药效学研究。临床试验及相关服务包括临床合同研究组织服务、一期临床研究协作单位 (CRU)，以及生物分析服务。实验模型业务主要包括啮齿类及非人灵长类动物。该公司在国内和海外市场开展业务。","exchange":"SEHK","nameEN":"JOINN","compareStock":{"symbol":"HSI","name":"恒生指数"}},"isWeiXinMini":false,"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情"}}